Styling practices can lead to serious hair and scalp diseases for some African Americans, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D. "Hair is an extremely important aspect of an African-American woman's appearance, " says Dr. Jackson-Richards, director of Henry Ford's Multicultural Dermatology Clinic. "Yet, many women who have a hair or scalp disease do not feel their physician takes them seriously. Physicians should become more familiar with the culturally accepted treatments for these diseases." Dr. Jackson-Richards says proper hair care can help prevent the onset of such diseases like seborrheic dermatitis and alopecia, and that dermatologists need to become more sensitive to the hair and scalp plights of African Americans. Dr. Jackson-Richards will discuss these issues Monday during a presentation of "Hair Disease and the African-American Patient" at the annual American Academy of Dermatology conference in San Diego.
Cytori Therapeutics (NASDAQ: CYTX) has announced the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology. RESTORE-2 is a 71 patient multi-center, prospective clinical trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat grafting for reconstruction of the breast after cancer surgery. The majority of patients underwent radiation prior to the procedure, creating an unfavorable ischemic environment for which breast reconstruction with ADRC-enriched fat grafting appears to be ideally suited. Key findings of the trial were: High rates of investigator (85%) and patient (75%) satisfaction with the overall treatment results at 12 months; High rates of investigator (87%) and patient (67%) satisfaction with overall breast deformity (based on functional and cosmetic outcomes) at 12 months;
Professor Laurence Kirwan, one of the world's leading plastic surgeons, who has appeared on BBC Breakfast to comment on the PIP breast implant scandal and who wrote in the Mail on Sunday (British newspaper) how cosmetic surgery can prolong life, has said that more and more young women between the ages of 35 and 40 years have cosmetic surgery. Professor Kirwan says that the number of women between 35 and 40 years who have cosmetic surgery every single year for 5 years has risen by 5%. He says that most young women opt for 'liquid lifts', injections of facial fillers, which typically consist of hyaluronic acid, a gel-like substance that occurs naturally in the skin and helps retain moisture to make cheeks look fuller and lift sagging jaws. The 'liquid lifts' together with Botox freeze the muscles to lift drooping eyebrows by interfering with nerve transmission.
Sientra Inc's silicone gel-filled breast implant for breast reconstruction or augmentation has been approved by the FDA, as long as the company carries out post-approval studies to assess the device's long-term effectiveness, safety, and rare disease outcomes. The implant is approved for females aged at least 22 years. These implants are surgically implanted either under the chest muscle or under breast tissue - the aim is to enlarge the breasts, or rebuild them after breast cancer surgery or some breast abnormality. This implant has an outer shell made of silicone, and is filled will silicone gel. Shells have either a smooth or textured surface, and come in various sizes. Breast reconstruction includes: The replacement of tissue taken out because of cancer or trauma Addition of tissue for a severe breast abnormality Revision surgery to improve or correct a previous primary breast reconstruction procedure Beast augmentation includes: Primary breast augmentation to make the breast bigger Revision surgery to correct or improve a previous breast augmentation procedure Including this latest approval, there are now three silicone gel-filled breast implants in America which are FDA-approved.
The UK Department of Health has issued an update on PiP breast implants scandal which struck in late 2011. Authorities have identified an additional 7, 000 women in the UK that may be in need to replacement or removal of their implants, and have confirmed this should be covered under the same NHS arrangements made earlier in the year. The additional patients have been identified from those who had surgery before 2011, where previously, the French Authorities who first investigated their local company, believed only those implants after 2001 were suspected of containing unauthorised silicone gel. It is generally recommended that implants are replaced every ten years, so many of these women may have already elected to replace their implants, or done so under NHS care. The NHS Medical Director, Professor Sir Bruce Keogh, continues to advise that there is not enough evidence to recommend routine removal of PiP breast implants They state on their website that : "However, we have always recommended that if women are concerned they should speak to their surgeon or GP.